The World's Greatest Investing Community
Results 1 - 10 of 46 : 1 2 3 4 5 Next
Dr. Reddy's Laboratories Misses Where It Counts
Just the facts, Fool.
Has Dr. Reddy's Labs Become the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
A Smarter Way to Invest in Emerging Markets: Dividends
Look for income from BRIC countries.
Dr. Reddy's Laboratories Beats Analyst Estimates on EPS
Just the facts, Fool.
Pozen Inks $75 Million Royalty Deal for Treximet
The pharma sells U.S. rights for the migraine drug to Canada's national pension fund.
Checking the Quality of Perrigo's Growth
These two simple metrics can save you a lot of pain.
The 20 Fastest Growers in Pharma
Yesterday's proven track records may reveal tomorrow's winners.
The 9 Top Value-Creating Pharmaceutical Companies
The top 9 companies in the pharmaceutical industry by EVA momentum.
Is Dr. Reddy’s Laboratories Going to Burn You?
Look here for a clue.
Why Dr. Reddy's Laboratories' Earnings Aren't So Hot
All cash flow is not created equal.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK